>
>

Coronary Stents Market – By Product, By Type, By Material, By End Use – Global Forecast, 2025 to 2034

Download Free PDF

Coronary Stents Market Size

The global coronary stents market size was valued at USD 7.5 billion in 2024 and is expected to exhibit growth at a CAGR of 7.2% from 2025 – 2034 period. The high market growth is driven by several factors such as the increasing prevalence of cardiovascular diseases, advancement in stent technology, growing elderly population, and rising number of minimally invasive surgeries.
 

Coronary Stents Market

The ever-growing demand for coronary stents is also caused by the increasing prevalence of coronary artery disease (CAD), which is the leading cause of death in the world. According to data provided by WHO, the number of lives taken away by cardiovascular diseases globally sums up to around 17.9 million on a yearly basis, making it the biggest reason for death. In addition to this, CDC estimates that around 18.2 million of the adult population above 20 in the U.S. have CAD. The high prevalence of CAD is caused by numerous factors such as sedentary lifestyle, poor food habits, use of tobacco and large aging population, which makes stents a vital treatment for such patients.

Moreover, the integration of advanced tools and technologies such as bioresorbable scaffolds, drug-eluting stents, and polymer-free stents minimizes the chances of thrombus and restenosis, which enhances the patient's recovery. With the improvement and development of such technologies, the trust of patients and clinicians in the effectiveness of stents increases, leading to their enhanced use.
 

Coronary stents are small mesh tubes that are fitted inside a coronary artery after percutaneous coronary intervention, coronary artery bypass surgery, or heart transplant. They are also used to treat patients suffering from coronary artery disease.
 

Coronary Stents Market Trends

The demand for coronary stents is on the rise as patients with vascular diseases benefit from their wider bioavailability. The increasing prevalence of vascular diseases such as strokes and heart attacks across developed regions of the world will have a positive impact on market growth. During the forecast period, coronary stents are expected to generate high revenue growth in markets due to the increasing demand for minimally invasive surgeries.
 

  • Irrespective of the worldwide geographic region, the morbid thrombosis and long-term requirement of administration of anti-platelet drugs will be eliminated with the increased use of bioabsorbable stents which dissolve with time. To avoid cases where permanent metal stents are not useful, BVS builds a scaffold that temporarily supports the stent and then dissolves in the body after the artery is healed.
     
  • Further, the ongoing strides in stent technology and increased clinical outcomes have resulted in more complex patients, including co-morbid, being referred for stent procedures increasing the market size. Since these technologies have made stent procedures possible for high-risk patients with minimal invasiveness, it has become more relevant in the coronary stent market in recent years.
     

Coronary Stents Market Analysis

Coronary Stents Market, By Product, 2021 – 2034 (USD Billion)

Based on product, the market is classified into drug-eluting stent, bioresorbable vascular scaffold (BVS), and bare metal stent. The drug eluting stent segment generated the highest revenue of USD 6.4 billion in 2024.
 

  • One of the major benefits of drug-eluting stents (DES) in comparison to bare-metal stents is the ability to deliver drugs to decrease further tissue growth. This enables a significant reduction in procedures aiming at addressing re-narrowing of an artery which improves the long-term results, hence making it the type of choice for most procedures in treating coronary artery disease.
     
  • In addition, imaging engineering consultants project that DES is associated with a lower risk of restenosis, hence fewer chances of needing additional interventions or repeat procedures when compared with bare metal stents. Desirable outcomes for patients, healthcare providers, and insurers are ensured from this low recurrence as it integrates reduced costs of healthcare with enhanced patient outcomes.
     

Based on type, the coronary stents market is classified into balloon expendable stent and self-expendable stent. The balloon expendable stent segment dominated the market in 2024 with a market share of 58.3%.
 

  • In complex or narrow arteries where a stent has to be precisely placed, balloon-expandable stents are ideal because of their effectiveness. During the implantation of balloon-expandable stents, many blood vessels suffer injury, so control is crucial. Balloon-expandable stents reduce the amount of damage the blood vessels suffer, enabling accurate placement of the stent.
     
  • Furthermore, balloon-expandable stents are also helpful for lesions that are more complex and have calcified lesions. Strong plaques or hardened blockages in the arterial walls which other types of stents would not be able to efficiently treat can be successfully treated by the use of high-deployed pressure stents as a result of balloon expansion. This is expected to fuel the development of the segment in the industry.
     

Based on material, the coronary stents market is segmented into cobalt-chromium alloy, stainless steel, and other materials. The cobalt-chromium alloy segment dominated the market in 2024 and is anticipated to reach USD 7.6 billion by the end of forecast period.
 

  • Cobalt-chromium alloy has a characteristic feature due to which it has unique tensile strength as well as durability which makes it ideal for the requirements for the stents as cobalt-chromium allows the stent to sustain over the pressure exerted by the walls of the artery which would allow for the widening of the internal diameter space within. There is a considerable difference as the strength of cobalt-chromium stents makes them survive longer thus avoiding cases of fractures and failures which would thereby improve the patient condition.
     
  • Moreover, cobalt-chromium's increased strength allows manufacturers to make thinner stent struts without sacrificing stability. They improve blood flow and healing due to the light strut designs, which also decrease the danger of arteries being injured. These advantages in particular help prevent the occurrence of stent restenosis (re-narrowing of arteries) and thrombosis and the segment's growth.

 

Coronary Stents Market, By End Use (2024)

Based on end use, the coronary stents market is segmented into cardiac centers, hospitals, ambulatory surgical centers, and other end users. The cardiac centers segment dominated the market in 2024 and is anticipated to reach USD 6.9 billion by the end of forecast period.
 

  • Cardiac centers have dedicated cardiologists, interventional radiologists, and cardiac surgeons, all of whom are highly trained in angioplasties, stent placements, and other highly technical procedures. Such expertise is needed with more difficult patients and situations, which is why cardiac centers are generally an excellent option for stent-related procedures.
     
  • Moreover, robotic-assisted systems, intravascular ultrasound (IVUS), and optical coherence tomography (OCT) are some of the diagnostic and interventional technologies that these centers use today. These aid in procedural accuracy in stent placement and minimize the chances of complications.

 

North America Coronary Stents Market, 2021 – 2034 (USD Billion)

North America coronary stents market accounted for USD 3 billion market revenue in 2024 and is anticipated to grow at a CAGR of 6.4% between 2025 – 2034 period.
 

  • In the U.S., along with the rest of North America, a very concerning statistic is the prevalence of CAD, a CVD. This promotes the use of stents as a form of CVD treatment.
     
  • In addition to this, the region is flooded with cutting-edge healthcare facilities alongside medical professionals that are highly trained. This mixture greatly aids in the growth of hospitals and cardiac centers within the region. This mix increases the availability of stents for CVD treatment and further accelerates the growth.
     

Germany coronary stents market is projected to grow remarkably in the coming years.
 

  • Germany is home to multiple stent manufacturing industries such as BIOTRONIK, B. Braun, and many more, there is a huge opportunity for the stent market to innovate and grow.
     
  • Moreover, stent placement is a part of the health insurance policy for German citizens, which drastically reduces the financial burden of the procedures. Stent procedures face little to no reimbursement policies, making them a good source of revenue.
     

China holds a dominant position in the Asia Pacific coronary stents market.
 

  • China has a high population over the age of 65 as compared to other countries. There is also an increasing number of people over the age of sixty-five, which means more people require CVD treatment. Age-related cardiovascular treatment is stent-based, and with an increasing number of heart-related diseases, more stent procedures will also be required.
     
  • Additionally, advanced hospitals and developing medical centers in both urban and rural regions have made a noticeable improvement in the healthcare system of the country. Improved accessibility and availability of advanced technologies such as coronary stents are also in high demand in urban hospitals that are equipped with the new available medical technologies, with the rest of the country being deficient in access to those tools.
     

Coronary Stents Market Share

The market is characterized by the presence of several key global players, including Abbott Laboratories, Boston Scientific, Medtronic, and BIOTRONIK. In addition, local companies have stepped up their operations in emerging markets, resulting in increased competition for cost-effective solutions for all. Moreover, as companies aim to increase their geographical and product variety range, innovation, strategic partnerships, and mergers/acquisitions dominate the landscape for competition.
 

Coronary Stents Market Companies

Prominent players operating in the coronary stents industry include:

  • Abbott Laboratories
  • Andramed GmbH
  • B. Braun Melsungen
  • Biosensors International Group
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical
  • Elixir Medical Corporation
  • GENOSS
  • Medtronic
  • Meril Life Science
  • MicroPort Scientific Corporation
  • Sahajanand Laser Technology
  • Stryker Corporation
  • Terumo Corporation
     

USPs for Top players:

  • Abbott has made significant progress in the field of engineering with the creation of newer drug-eluting stents for vascular healing. This innovation allows for a long-term geometrical vascular outcome.
     
  • Boston Scientific offers an array of stents boasting the latest technology for improved deliverability and enhanced robustness. They provide a wide range of options for the consumer.
     
  • Medtronic stent systems are exceptionally well known for their non-invasive treatment that offers high accuracy and exceptional durability.
     

Coronary Stents Industry News:

  • In May 2024, Abbott announced the launch of its XIENCE sierra everolimus-eluting coronary stent system in India. As one of the latest-generation stents in the XIENCE family, XIENCE sierra became available to patients with blocked coronary arteries. Designed for use in complex cases, the stent offers interventional cardiologists a high level of safety and reliability.
     
  • In August 2022, Medtronic announced the launch of its latest drug-eluting coronary stent, the Onyx Frontier DES, following recent CE Mark approval. It introduced an advanced delivery system, enhancing upon the proven performance and clinical data of the Resolute Onyx DES. This stent leverages the same high-performing platform as Resolute Onyx, with an optimized delivery system designed to improve ease of use and deliver superior acute performance, even in complex cases.
     

The coronary stents market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Product

  • Drug-eluting stent
  • Bioresorbable vascular scaffold (BVS)
  • Bare metal stent

Market, By Type

  • Balloon expendable stent
  • Self-expendable stent

Market, By Material

  • Cobalt-chromium alloy
  • Stainless steel
  • Other materials

Market, By End Use

  • Cardiac centers
  • Hospitals
  • Ambulatory surgical centers
  • Other end users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada 
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Mariam Faizullabhoy , Gauri Wani
Frequently Asked Question(FAQ) :
Who are some of the prominent players in the coronary stents industry?
Key players in the industry include Abbott Laboratories, Andramed GmbH, B. Braun Melsungen, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Elixir Medical Corporation, GENOSS, Medtronic, and Meril Life Science.
How much is the North America coronary stents industry worth?
How big is the global coronary stents market?
Why are drug-eluting stents preferred over bare-metal stents?
Coronary Stents Market Scope
  • Coronary Stents Market Size
  • Coronary Stents Market Trends
  • Coronary Stents Market Analysis
  • Coronary Stents Market Share
Related Reports
    Authors: Mariam Faizullabhoy , Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2024

    Companies covered: 15

    Tables & Figures: 108

    Countries covered: 19

    Pages: 130

    Download Free PDF

    Top